Form 10-C
Securities and Exchange Commission
Washington, DC 20549
Report by issuer of securities quoted on The Nasdaq Stock Market(SM), filed
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule
13a-17 or 15d-17 thereunder.
EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER: Medtronic InStent, Inc.
ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 6271 Bury Drive, Eden Prairie, MN 55346
ISSUER'S TELEPHONE NUMBER (INCLUDING AREA CODE): (612) 937-0322
I. Change in Number of Shares Outstanding
Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:
1. Title of security: Common Stock, par value $0.01
2. Number of shares outstanding before the change: 10,043,427
3. Number of shares outstanding after the change: 100
4. Effective date of change: June 28, 1996
5. Method of change: Decrease in number of outstanding shares
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.): Merger of BYR
Acquisition Corp. ("BYR") into Issuer
Give brief description of transaction: Outstanding shares of the Issuer were
converted into shares of Medtronic, Inc., and each outstanding share of BYR was
converted into one share of the Issuer.
II. Change in Name of Issuer
1. Name prior to change: InStent, Inc.
2. Name after change: Medtronic InStent, Inc.
3. Effective date of charter amendment changing name: June 28, 1996
4. Date of shareholder approval of change, if required: June 28, 1996
July 12, 1996 /s/ Sven Wehrwein, Chief Financial Officer
DATE OFFICER'S SIGNATURE AND TITLE
